From: [177Lu]Lu-DOTA-ZOL bone pain palliation in patients with skeletal metastases from various cancers: efficacy and safety results
Response (VAS criteria)
Number of patients (N)
Baseline AS (median, IQR)
Post-treatment AS (median, IQR)
P value
CR
11
6 (6–8)
2 (1.2–2.7)
0.001
PR
20
7 (6–8)
3 (3–3.5)
< 0.0001
MR
5
8 (6–8.25)
4.8 (4–6)
0.006
NR
4
8.5 (8–12.5)
8 (8–12)
0.918